Skip to main content
Elos Medtech logo

Elos Medtech — Investor Relations & Filings

Ticker · ELOS ISIN · SE0000120776 LEI · 529900I5MSNU451FL670 ST Manufacturing
Open in API
Filings indexed 331 across all filing types
Latest filing 2011-08-18 Interim / Quarterly Rep…
Country SE Sweden
Listing ST ELOS

About Elos Medtech

http://elosmedtech.com

Elos Medtech is a contract development and manufacturing organization (CDMO) specializing in the medical device sector. The company partners with medical technology firms, providing comprehensive services that span the entire product lifecycle, from research and development to manufacturing and commercialization. Its core focus areas include dental, orthopedics, and advanced surgical products. Elos Medtech offers a range of capabilities, including precision manufacturing, polymer injection molding, process optimization, packaging, and regulatory support. The company operates through specialized business units that collaborate to provide clients with tailored solutions, aiming to streamline operations, reduce complexity, and accelerate innovation in the medical device field.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2011
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for the period 1 January – 30 June 2011. It contains comprehensive financial statements, including income statements, balance sheets, cash flow analysis, and detailed management commentary on business segments (Medicinteknik and Mätteknik). It is a full financial report for a period shorter than a fiscal year, not an announcement or a summary, thus fitting the definition of an Interim/Quarterly Report. H1 2011
2011-08-18 Swedish
Elos har utsett Ulrica Ehn till ny CFO
Board/Management Information Classification · 98% confidence The document is a short press release announcing a specific change in senior personnel: the appointment of Ulrica Ehn as the new CFO. This directly corresponds to the definition of 'Board/Management Information' (MANG), which covers announcements of changes in the company's board of directors or senior management. The document is not a full financial report (10-K, IR), an earnings release (ER), or a proxy statement (DEF 14A/PSI).
2011-08-17 Swedish
Elos genomför ett strategiskt förvärv vilket utvecklar erbjudandet inom Medicinteknik
M&A Activity Classification · 98% confidence The document is explicitly titled 'Pressrelease' and details the acquisition of Microplast AB by Elos AB. This transaction involves a merger/takeover activity, which aligns with the definition for M&A Activity (TAR). Although it is a press release, the core subject matter is a strategic acquisition, making TAR more specific than a general Regulatory Filing (RNS) or Report Publication Announcement (RPA), especially since the document itself contains the substance of the M&A event, not just an announcement that a report is attached. The document length (2630 chars) is sufficient to convey the details of the transaction.
2011-06-30 Swedish
Elos AB – Teckning genomförd av Elos Konvertibler 2011/2014
Capital/Financing Update Classification · 99% confidence The document is titled 'Pressrelease' and details the completion ('Teckning genomförd') of a convertible bond issuance ('Elos Konvertibler 2011/2014'). It specifies the issue amount (10,999,000 kr), the number of convertibles, the conversion price (85 kr), and the interest rate. This content directly relates to the company raising capital or changing its capital structure through debt instruments that can be converted into equity. This aligns perfectly with the definition for Capital/Financing Update (CAP). It is not an earnings release (ER), an annual report (10-K), or a general regulatory filing (RNS), as it concerns a specific financing event.
2011-06-16 Swedish
Elos AB – Fastställda villkor för konvertibelt förlagslån
Capital/Financing Update Classification · 99% confidence The document is titled 'Pressrelease' and details the final terms ('Fastställda villkor') for a convertible subordinated loan ('konvertibelt förlagslån') involving the issuance of convertible notes. This announcement concerns the terms of financing, capital structure changes, and the mechanism for future share issuance upon conversion. This aligns best with the 'Capital/Financing Update' category (CAP), as it is a specific announcement about raising capital through debt convertible into equity, rather than a general regulatory filing (RNS) or a full annual/interim report. The document is short and functions as a direct announcement of financing terms.
2011-05-17 Swedish
Elos AB (publ) – Årsstämma 2011
AGM Information Classification · 99% confidence The document is explicitly titled 'Elos AB (publ) – Årsstämma 2011' (Annual General Meeting 2011) and details the resolutions passed during this meeting, such as dividend approval, employee convertible loan issuance, board member re-elections, and authorization for new share issues. These are core topics discussed and decided upon at an Annual General Meeting (AGM). Therefore, the classification is AGM-R (AGM Information). The document is a summary of the meeting outcomes, not a proxy statement (PSI) or a general regulatory filing (RNS).
2011-05-04 Swedish

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.